Difference between revisions of "Corticobasal syndrome / corticobasal degeneration"

(Created page with "'''Diagnosis''' CBS clinical criteria 111 (note that other clinical phenotypes, including FBS, naPPA, and PSP may also have CBD pathology) 1) Probable CBS :a. Must have asy...")
 
Line 1: Line 1:
 
'''Diagnosis'''
 
'''Diagnosis'''
  
CBS clinical criteria 111 (note that other clinical phenotypes, including FBS, naPPA, and PSP may also have CBD pathology)
+
CBS clinical criteria (Armstrong 2013) (note that other clinical phenotypes, including FBS, naPPA, and PSP may also have CBD pathology)
  
 
1) Probable CBS
 
1) Probable CBS
Line 43: Line 43:
 
::iii. Alien limb phenomena (more than simple levitation)
 
::iii. Alien limb phenomena (more than simple levitation)
  
- patients with CBS will often have deficits within domains of executive functioning, writing, as and visuospatial construction 95
+
- patients with CBS will often have deficits within domains of executive functioning, writing, as and visuospatial construction (Finger 2016)
  
- neuroimaging shows asymmetric frontal and parietal lobe atrophy 95
+
- neuroimaging shows asymmetric frontal and parietal lobe atrophy (Finger 2016
  
  
Other possible presentations of underlying corticobasal degeneration pathology: 111
+
Other possible presentations of underlying corticobasal degeneration pathology: (Armstrong 2013)
  
 
1) Frontal behavioral-spatial syndrome
 
1) Frontal behavioral-spatial syndrome
Line 66: Line 66:
  
 
'''Pathology'''
 
'''Pathology'''
Proposed pathologic criteria for the diagnosis of CBD require: 111
+
 
 +
Proposed pathologic criteria for the diagnosis of CBD require: (Armstrong 2013)
 +
 
 
:a) The detection of characteristic tau-immunoreactive lesions in the neurons, glia, and cell processes of the cortex and striatum (caudate and putamen), particularly astrocytic plaques and thread-like lesions in both white matter and gray matter
 
:a) The detection of characteristic tau-immunoreactive lesions in the neurons, glia, and cell processes of the cortex and striatum (caudate and putamen), particularly astrocytic plaques and thread-like lesions in both white matter and gray matter
  
Line 78: Line 80:
  
 
== References ==
 
== References ==
 +
 +
Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496–503 (2013). https://pubmed.ncbi.nlm.nih.gov/23359374/
 +
 +
Finger, E. C. Frontotemporal Dementias. Contin. Minneap. Minn 22, 464–489 (2016). https://pubmed.ncbi.nlm.nih.gov/27042904/

Revision as of 12:06, 12 June 2021

Diagnosis

CBS clinical criteria (Armstrong 2013) (note that other clinical phenotypes, including FBS, naPPA, and PSP may also have CBD pathology)

1) Probable CBS

a. Must have asymmetric presentation
b. Must have at least two of the following:
i. Limb rigidity or akinesia
ii. Limb dystonia
iii. Limb myoclonus
c. Must have at least two of the following:
i. Orobuccal or limb apraxia
ii. Cortical sensory deficit (i.e. agraphesthesia, astereognosis)
iii. Alien limb phenomena (more than simple levitation)

2) Possible CBS

a. Must have asymmetric presentation
b. Must have at least one of the following:
i. Limb rigidity or akinesia
ii. Limb dystonia
iii. Limb myoclonus
c. Must have at least one of the following:
i. Orobuccal or limb apraxia
ii. Cortical sensory deficit
iii. Alien limb phenomena (more than simple levitation)

- patients with CBS will often have deficits within domains of executive functioning, writing, as and visuospatial construction (Finger 2016)

- neuroimaging shows asymmetric frontal and parietal lobe atrophy (Finger 2016


Other possible presentations of underlying corticobasal degeneration pathology: (Armstrong 2013)

1) Frontal behavioral-spatial syndrome

a. Must have at least two of the following:
i. Executive dysfunction
ii. Behavioral or personality changes
iii. Visuospatial deficits

2) Non-fluent/agrammatic PPA (naPPA), see PPA chapter

3) PSP syndrome, see PSP


Pathology

Proposed pathologic criteria for the diagnosis of CBD require: (Armstrong 2013)

a) The detection of characteristic tau-immunoreactive lesions in the neurons, glia, and cell processes of the cortex and striatum (caudate and putamen), particularly astrocytic plaques and thread-like lesions in both white matter and gray matter
b) In conjunction with neuronal loss in focal cortical regions and in the substantia nigra
c) Supportive features include ballooned cortical neurons, cortical atrophy, and tau-positive oligodendroglial coiled bodies

- pathology is typically 4R tau (CBD) > (Alzheimer’s pathology) > PSP, TDP-43 > 3R tau 92


References

Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496–503 (2013). https://pubmed.ncbi.nlm.nih.gov/23359374/

Finger, E. C. Frontotemporal Dementias. Contin. Minneap. Minn 22, 464–489 (2016). https://pubmed.ncbi.nlm.nih.gov/27042904/